Composition comprising biosurfactant and pesicomycin

By using a composition containing biosurfactant and persicomycin, the problems of existing detergents in removing fat stains in fabrics and completely flushing from the surface are solved, achieving efficient cleaning and low environmental impact effects.

CN119452068APending Publication Date: 2025-02-14EVONIK OPERATIONS GMBH
View PDF 61 Cites 0 Cited by

Patent Information

Application Number
CN202380050667.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-06-28
Filing Date
2023-06-19
Publication Date
2025-02-14

AI Technical Summary

Technical Problem

Existing cleaners are not effective in removing fat stains from fabrics and are difficult to completely rinse off the cleaned surface.

Method used

Compositions containing biosurfactants and persicomycin are employed to improve cleaning performance by their special properties, especially in removing fat stains and rinsing the cleaner from the fibers.

Benefits of technology

Efficient removal of fat stains is achieved, and the detergent is easily rinsed from the cleaned surface, supporting enzyme storage stability and providing pure biodetergents and low total surfactant loads.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005214953870000041
    Figure BDA0005214953870000041
  • Figure BDA0005214953870000081
    Figure BDA0005214953870000081
  • Figure BDA0005214953870000091
    Figure BDA0005214953870000091
Patent Text Reader

Abstract

The present invention relates to a composition comprising at least one biosurfactant and at least one persicmycin.
Need to check novelty before this filing date? Find Prior Art

Description

Field of the Invention

[0001] The present invention relates to compositions comprising at least one biosurfactant and at least one persicomycin. Prior art

[0002] Persicomycins are 3-(3'-hydroxy)hydroxy fatty acids and represent a family of plant bacterial toxins. They are associated with necrosis in peach trees, with 3-(3'-hydroxydecanoyloxy)hexadecenoic acid being the most prominent persicomycin, see Eur J Biochem. 1996 Sep 1; 239(3):702-9.

[0003] EP2797571 discloses a composition comprising water, at least one biosurfactant and at least one fatty acid, wherein the fraction of the sum of all surfactants in the composition is 1 to 30% by weight and the fraction of the fatty acid, based on the sum of fatty acid and surfactant, is 0.1 to 20% by weight.

[0004] It is an object of the present invention to provide compositions having excellent cleaning ability, especially in home care applications.

[0005] Description of the invention

[0006] Surprisingly it has been found that compositions comprising at least one biosurfactant and at least one persicomycin have specific properties that are well suited for cleaning applications.

[0007] The present invention therefore provides a composition comprising:

[0008] A) at least one biosurfactant, and

[0009] B) at least one persicomycin.

[0010] The invention further provides a method for cleaning an article as described in more detail in claim 9.

[0011] An advantage of the present invention is that the compositions of the present invention have very good cleaning performance, especially in removing fatty stains from fabrics.

[0012] Another advantage of the present invention is that the compositions of the present invention can be rinsed very easily from cleaned surfaces, preferably from fibers.

[0013] A further advantage is that the composition of the invention supports the stability of the enzyme on storage.

[0014] One advantage of the present invention is that a purely biological detergent is provided by the composition of the present invention, all ingredients of which are of biological origin.

[0015] Another advantage of the present invention is that detergents having lower overall surfactant loadings while maintaining cleaning ability are provided by the compositions of the present invention.

[0016] Another advantage of the present invention is that the detergent has improved performance, especially on fatty stains.

[0017] A further advantage is that the compositions of the present invention provide high performance detergents using fewer ingredients. Thus, formulation complexity is greatly reduced, making the manufacturing process simpler.

[0018] Another advantage of the present invention is that the formulations exhibit particularly good emulsifying and dispersing properties.

[0019] Another advantage of the present invention is that detergents using mild surfactants having low water toxicity are provided by the compositions of the present invention.

[0020] Another advantage of the present invention is that the compositions of the present invention can be formulated to be 100% biodegradable.

[0021] Another advantage is that the formulation exhibits excellent compatibility with all materials contained in washing machines in terms of corrosion.

[0022] Another advantage is that the formulation can be diluted very easily with water without excessive stirring.

[0023] One advantage of the present invention is that the compositions according to the invention have a positive odor profile.

[0024] Another advantage of the present invention is that the composition according to the present invention has improved color stability. The color change reaction may come from the Maillard reaction, which is a chemical reaction between proteins or amino acids and sugars. In fermentation-produced biosurfactants such as rhamnolipids, sophorolipids or Rubiwettin, small amounts of reaction partners, proteins and sugars are usually contained. These small concentrations are sufficient to change the color from light to dark.

[0025] A further advantage is that the compositions according to the invention have improved surface cleaning properties.

[0026] Another advantage is that the compositions according to the invention have excellent foaming properties.

[0027] A further advantage is that the compositions according to the invention have reduced irritation to human skin.

[0028] Another advantage lies in the mildness and good physiological compatibility of the compositions according to the invention, characterized in particular by high values ​​in the red blood cell (RBC) test.

[0029] A further advantage is the good skin feel of the compositions according to the invention during and after washing.

[0030] Another advantage is that the compositions according to the invention leave a smooth and soft skin feel after washing.

[0031] A further advantage lies in the excellent microbial stability of the compositions according to the invention.

[0032] Another advantage is that the compositions according to the invention have an improved ability to dissolve oils and fats.

[0033] Another advantage is that the composition according to the invention has a higher viscosity than a corresponding composition without persicomycin.

[0034] The present invention provides a composition comprising

[0035] A) at least one biosurfactant, and

[0036] B) at least one persicomycin, preferably 3-(3'-hydroxydecanoyloxy)hexadecenoic acid.

[0037] In the context of the present invention, "biosurfactants" are understood to mean all glycolipids produced by fermentation. The term "biosurfactant" also encompasses glycolipids that have been chemically or enzymatically modified after fermentation, as long as the glycolipid is retained structurally.

[0038] Raw materials for the production of biosurfactants which can be used are carbohydrates, in particular sugars, for example glucose and / or lipophilic carbon sources, such as fats, oils, partial glycerides, fatty acids, fatty alcohols, long-chain saturated or unsaturated hydrocarbons.

[0039] In the context of the present invention, the term "surfactant" is understood to mean an organic substance with interface-active properties which is able to reduce the surface tension of water to below 45 mN / m at 20° C. and at a concentration of 0.5% by weight, based on the total composition. The surface tension is determined by the Du Noüy ring method at 20° C.

[0040] In the context of the present invention, "persicomycins" are understood to mean 3-(3'-hydroxy)hydroxy fatty acids and the corresponding salts thereof.

[0041] Where average values ​​are stated hereinafter, these are number average values ​​unless otherwise stated.

[0042] Unless otherwise stated, percentages are given in percent by weight.

[0043] Wherever measured values ​​are stated hereinafter, these were determined at a temperature of 25° C. and a pressure of 1013 mbar, unless stated otherwise.

[0044] The composition according to the invention preferably comprises as component A) at least one biosurfactant selected from rhamnolipids, sophorolipids, glucolipids, cellulose lipids, mannoerythritol lipids and trehalolipids, preferably rhamnolipids, sophorolipids and glucolipids, most preferably rhamnolipids. Biosurfactants can be produced, for example, as described in EP 0499434, US 7,985,722, WO 03 / 006146, JP 60183032, DE 19648439, DE 19600743, JP 01304034, CN1337439, JP 2006274233, KR2004033376, JP 2006083238, JP 2006070231, WO 03 / 002700, FR2740779, DE2939519, US 7,556,654, FR 2855752, EP 1445302, JP 2008062179 and JP2007181789 or the literature cited therein. Suitable biosurfactants are available from, for example, Soliance, France.

[0045] Preferably, the composition according to the invention has as biosurfactant at least one member selected from rhamnolipids, in particular mono-, di- or polyrhamnolipids, glucose lipids, in particular mono-, di- or polyglucose lipids, and sophorolipids, in particular mono-, di- or polysophorolipids, preferably selected from rhamnolipids and glucose lipids, most preferably rhamnolipids.

[0046] The term "rhamnolipid" in the context of the present invention is preferably understood to mean in particular compounds of the general formula (I) and their salts,

[0047]

[0048] in

[0049] mRL=2, 1 or 0,

[0050] nRL=1 or 0,

[0051] R 1RL and R 2RL = independently of one another are identical or different organic residues having 2 to 24, preferably 5 to 13 carbon atoms, in particular optionally branched, optionally substituted, in particular hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or tri-unsaturated alkyl residues, preferably selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl and tridecenyl and (CH 2 )o -CH 3 Those wherein o=1-23, preferably 4-12.

[0052] If nRL = 1, the glycosidic bond between the two rhamnose units is preferably in the α-configuration. The optically active carbon atom of the fatty acid is preferably present as the R-enantiomer (e.g. (R)-3-{(R)-3-[2-O-(α-L-rhamnopyranosyl)-α-L-rhamnopyranosyl]oxydecanoyl}oxydecanoate).

[0053] The term "diarhamnolipid" is understood in the context of the present invention to mean a compound of the general formula (I) or a salt thereof in which nRL=1.

[0054] The term "monorhamnolipid" is understood in the context of the present invention to mean a compound of the general formula (I) or a salt thereof in which nRL=0.

[0055] The different rhamnolipids are abbreviated according to the following nomenclature:

[0056] "diRL-CXCY" is understood to mean a dirhamnolipid of the general formula (I) in which the residue R 1RL and R 2RL One = (CH 2 ) o -CH 3 , where o = X-4, and the remaining residue R 1RL or R 2RL =(CH 2 ) o -CH 3 , where o=Y-4.

[0057] "monoRL-CXCY" is understood to mean a monorhamnolipid of the general formula (I) in which the residue R 1RL and R 2RL One = (CH 2 ) o -CH 3 , where o = X-4, and the remaining residue R 1RL or R 2RL =(CH 2 ) o -CH 3 , where o=Y-4.

[0058] Therefore, the nomenclature used does not distinguish between "CXCY" and "CYCX".

[0059] For rhamnolipids where mRL=0, monoRL-CX or diRL-CX was used accordingly.

[0060] If one of the above labels X and / or Y is accompanied by ":Z", this means that the corresponding residue R 1RL and / or R 2RL Equivalent to an unbranched, unsubstituted hydrocarbon residue having X-3 or Y-3 carbon atoms with Z double bonds.

[0061] Methods for preparing related rhamnolipids are disclosed in, for example, EP2786743 and EP2787065.

[0062] Rhamnolipids suitable for use in the context of the present invention can also be produced by fermentation of Pseudomonas, especially Pseudomonas aeruginosa, which is preferably a non-genetically modified cell, which is a technology that has been disclosed in the 1980s, such as described in, for example, EP0282942 and DE4127908. Rhamnolipids produced in Pseudomonas aeruginosa cells that have been improved by genetic modification for higher rhamnolipid titers can also be used in the present invention; for example, Lei et al. disclose such cells in Biotechnol Lett. 2020Jun; 42(6): 997-1002.

[0063] Rhamnolipids produced by Pseudomonas aeruginosa are available from Jeneil Biotech Inc., for example under the trade name Zonix, from Logos Technologies (technology acquired by Stepan), for example under the trade name NatSurFac, from Biotensidion GmbH, for example under the trade name Rhapynal, from AGAE technologies, for example under the names R90, R95, R95Md, R95Dd, from Locus Bio-Energy Solutions and from Shanghai Yusheng Industry Co. Ltd., for example under the trade name Bio-201 Glycolipids.

[0064] The present invention provides a composition preferably comprising rhamnolipids as biosurfactants, characterized in that the biosurfactant component A) comprises

[0065] 51 to 100% by weight, preferably 60 to 95% by weight, particularly preferably 80 to 90% by weight, of monorhamnolipids, especially those of the formula (I) in which nRL=0,

[0066] The percentages by weight refer to the sum of all rhamnolipids present.

[0067] This surprisingly increases the viscosity of the composition according to the invention. Preferably, this preferred embodiment is combined with a certain content of a detergent (see below), preferably of the carboxymethylinulin type.

[0068] The present invention further provides a composition preferably comprising rhamnolipids as biosurfactants, characterized in that the biosurfactant component A) comprises

[0069] 51 to 95% by weight, preferably 55 to 80% by weight, particularly preferably 60 to 70% by weight, of diRL-C10C10,

[0070] The percentages by weight refer to the sum of all rhamnolipids present.

[0071] A preferred composition according to the invention is characterized in that it comprises a rhamnolipid as described above as a biosurfactant in an amount of

[0072] 0.5 to 15% by weight, preferably 3 to 12% by weight, particularly preferably 5 to 10% by weight, of diRL-C10C12:1,

[0073] The percentages by weight refer to the sum of all rhamnolipids present.

[0074] A further preferred composition according to the invention is characterized in that the composition comprises rhamnolipid as described above as a biosurfactant in an amount of

[0075] 0.5 to 25% by weight, preferably 3 to 15% by weight, particularly preferably 5 to 12% by weight, of diRL-C10C12,

[0076] The percentages by weight refer to the sum of all rhamnolipids present.

[0077] A further preferred composition according to the invention is characterized in that the composition comprises rhamnolipid as described above as a biosurfactant in an amount of

[0078] 0.1 to 25% by weight, preferably 2 to 10% by weight, particularly preferably 4 to 8% by weight, of diRL-C8C10,

[0079] The percentages by weight refer to the sum of all rhamnolipids present.

[0080] A further preferred composition according to the invention is characterized in that the composition comprises rhamnolipid as described above as a biosurfactant in an amount of

[0081] 0.1% to 5% by weight, preferably 0.5% to 3% by weight, particularly preferably 0.5% to 2% by weight of monoRL-C8C10 and / or, preferably and

[0082] 0.1 to 5% by weight, preferably 0.5 to 3% by weight, particularly preferably 0.5 to 2% by weight, of monoRL-C10C10,

[0083] The percentages by weight refer to the sum of all rhamnolipids present.

[0084] The present invention provides a composition which alternatively preferably comprises rhamnolipids as biosurfactants, characterized in that the biosurfactant component A) comprises

[0085] 10 to 50% by weight, preferably 20 to 40% by weight, particularly preferably 25 to 35% by weight of monoRL-C10C10 and

[0086] The percentages by weight refer to the sum of all rhamnolipids present.

[0087] An alternative preferred composition according to the invention is preferably characterized in that the composition comprises a rhamnolipid as described above as a biosurfactant in an amount of

[0088] 10 to 30% by weight, preferably 12 to 25% by weight, particularly preferably 15 to 20% by weight, of diRL-C10C10,

[0089] The percentages by weight refer to the sum of all rhamnolipids present.

[0090] An alternative preferred composition according to the invention is preferably characterized in that the composition comprises a rhamnolipid as described above as a biosurfactant in an amount of

[0091] 10% to 30% by weight, preferably 12% to 25% by weight, particularly preferably 15% to 20% by weight, of monoRL-C8C10,

[0092] The percentages by weight refer to the sum of all rhamnolipids present.

[0093] An alternative preferred composition according to the invention is preferably characterized in that the composition comprises a rhamnolipid as described above as a biosurfactant in an amount of

[0094] 3 to 25% by weight, preferably 5 to 20% by weight, particularly preferably 10 to 15% by weight, of monoRL-C10C12:1,

[0095] The percentages by weight refer to the sum of all rhamnolipids present.

[0096] An alternative preferred composition according to the invention is preferably characterized in that the composition comprises a rhamnolipid as described above as a biosurfactant in an amount of

[0097] 1 to 15% by weight, preferably 2 to 10% by weight, particularly preferably 3 to 8% by weight, of diRL-C10C12,

[0098] The percentages by weight refer to the sum of all rhamnolipids present.

[0099] Methods for preparing related rhamnolipids are disclosed in, for example, EP2786743 and EP2787065.

[0100] Rhamnolipids suitable for the present invention can also be produced by fermentation of Pseudomonas, especially Pseudomonas aeruginosa, which is preferably a non-genetically modified cell, which is a technology that has been disclosed in the 1980s, such as described in, for example, EP0282942 and DE4127908. Rhamnolipids produced in Pseudomonas aeruginosa cells that have been improved by genetic modification for higher rhamnolipid titers can also be used in the present invention; for example, Lei et al. disclose such cells in Biotechnol Lett. 2020Jun; 42(6): 997-1002.

[0101] Rhamnolipids produced by Pseudomonas aeruginosa are available from Jeneil Biotech Inc., for example under the trade name Zonix, from Logos Technologies (technology acquired by Stepan), for example under the trade name NatSurFac, from Biotensidion GmbH, for example under the trade name Rhapynal, from AGAE technologies, for example under the names R90, R95, R95Md, R95Dd, from Locus Bio-Energy Solutions and from Shanghai Yusheng Industry Co. Ltd., for example under the trade name Bio-201 Glycolipids.

[0102] In the present invention, the term "sophorolipid" is preferably understood to mean compounds of the general formula (IIa) and (IIb) and their salts

[0103]

[0104] in

[0105] R1SL =H or CO-CH 3 ,

[0106] R 2SL =H or CO-CH 3 ,

[0107] R 3SL = a divalent organic moiety comprising 6 to 32 carbon atoms and which is unsubstituted or substituted by hydroxyl functions, unbranched and optionally comprising 1 to 3 double or triple bonds,

[0108] R 4SL =H、CH 3 or a monovalent organic radical comprising 2 to 10 carbon atoms and which is unsubstituted or substituted with hydroxyl functions, unbranched and optionally comprising 1 to 3 double or triple bonds, and

[0109] nSL=1 or 0.

[0110] The sophorolipids can be used according to the invention in their acid form or in their lactone form.

[0111] Preferred compositions according to the invention comprise sophorolipids in which the weight ratio of lactone form to acid form is between 20:80 and 80:20, particularly preferably between 30:70 and 40:60.

[0112] To determine the content of sophorolipids in the acid or lactone form in a preparation, reference is made to EP 1 41 1 1 1 B1 , page 8, paragraph

[0053] .

[0113] In connection with the present invention, the term "glucose lipids" is preferably understood to mean compounds of the general formula (III) and their salts,

[0114]

[0115] in

[0116] mGL=3, 2, 1 or 0, preferably 1 or 0,

[0117] R 1GL and R 2GL = independently of one another are identical or different organic radicals having 2 to 24 carbon atoms, in particular optionally branched, optionally substituted, in particular hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or tri-unsaturated alkyl radicals, preferably selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl and tridecenyl and (CH 2 ) o -CH 3 wherein o=1 to 23, preferably 4 to 12.

[0118] The different glucose lipids are abbreviated according to the following nomenclature:

[0119] "GL-CXCY" is understood to mean a glucose lipid of the general formula (III) in which the radical R 1GL and R 2GL One = (CH 2 ) o -CH 3 , where o = X-4, and the remaining groups R 1GL or R 2GL =(CH 2 ) o -CH 3 , where o=Y-4.

[0120] Therefore, the nomenclature used does not distinguish between "CXCY" and "CYCX".

[0121] If one of the above symbols X and / or Y carries ":Z", this means that the corresponding group R 1GL and / or R 2GL = an unbranched, unsubstituted hydrocarbon radical having X-3 or Y-3 carbon atoms with Z double bonds.

[0122] The method for producing glucose lipids can be carried out as described in WO2019154970.

[0123] Preferred compositions according to the invention are characterized in that the ratio of component B) to component A) is from 1:2000 to 1:3, preferably from 1:1000 to 1:10, more preferably from 1:300 to 1:20, most preferably from 1:100 to 1:25.

[0124] When determining the content of components A) and B) in the present invention, the mass in non-salt form is taken into account; therefore, the weight of the corresponding cation is not taken into account.

[0125] Preferred compositions according to the invention further comprise

[0126] C) at least one enzyme, preferably selected from the group consisting of proteases, amylases, lipases, pectinases, cellulases, phosphodiesterases, mannanases, cutinases, pectate lyases, peroxidases, oxidases and laccases.

[0127] Enzymes are useful additives in laundry compositions. Preferably the enzymes comprised in the compositions according to the invention are selected from the group consisting of proteases, amylases, lipases, pectinases, cellulases, phosphodiesterases, mannanases, cutinases, pectate lyases, peroxidases, oxidases and laccases, wherein proteases, amylases, lipases, pectinases, cellulases, phosphodiesterases and mannanases are particularly preferred.

[0128] The enzymes used in the present invention may, for example, be originally derived from microorganisms, such as microorganisms of the genera Bacillus, Streptomyces, Humicola or Pseudomonas, and / or be produced by suitable microorganisms according to known biotechnological methods, for example by means of transgenic expression hosts, such as those of the genera Escherichia, Bacillus or filamentous fungi.

[0129] It is emphasized that it can also be, in particular, an industrial enzyme preparation of the corresponding enzyme, ie accompanying substances may be present. The enzyme can thus be packaged and used together with accompanying substances (eg from fermentation) or with further stabilizers.

[0130] Suitable proteases include those of bacterial, fungal, plant, viral or animal origin, such as those of plant or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included. It can be an alkaline protease, such as a serine protease or a metalloprotease. The serine protease can be, for example, the S1 family, such as trypsin, or the S8 family, such as subtilisin. Metalloproteases can be, for example, thermolysin or other metalloproteases from, for example, the M4 family, such as those from the M5, M7 or M8 families.

[0131] Examples of proteases are subtilisin BPN from Bacillus amyloliquefaciens and Carlsberg from Bacillus licheniformis, protease PB92, subtilisin 147 and 309, protease from Bacillus lentus, subtilisin DY and subtilase, but no longer designated as subtilisin in a narrower sense, thermophilic protease (Thermitase), proteinase K and proteases TW3 and TW7.

[0132] Subtilisin Carlsberg is sold under the trade name A further developed form from Novozymes A / S, Bagsvasrd, Denmark.

[0133] Subtilisin 147 and 309 are produced by Novozymes under the trade names and For sale. The protease variant of is derived from the protease from Bacillus lentus DSM 5483. Further useful proteases are, for example, those from Novozymes under the trade name and Those from Danisco / Genencor under the trade name OxP, Prime, and It is marketed under the trade name of It is marketed under the trade name of Wuxi Snyder Bioproducts Ltd., China. It is marketed under the trade name Amano Pharmaceuticals Ltd., Nagoya, Japan. and The enzyme is commercially available from Kao Corp., Tokyo, Japan, and is available under the name Proteinase K-16.

[0134] Particular preference is also given to using the proteases from Bacillus gibsonii and Bacillus pumilus disclosed in International Patent Applications WO 08 / 086916 and WO 07 / 131656.

[0135] Further advantageously usable proteases are disclosed in patent applications WO 91 / 02792, WO 08 / 007319, WO 93 / 18140, WO 01 / 44452, GB 1243784, WO 96 / 34946, WO 02 / 029024 and WO 03 / 057246. Other proteases which can be used are those found in the naturally occurring microorganism Stenotrophomonas maltophilia, in particular Stenotrophomonas maltophilia K279a, Bacillus intermedius and Bacillus sphaericus.

[0136] Other commercially available proteases are: EC 3.5L, EC 3.5L, 3.5L, 3.5L, Preferenz P100, Preferenz P200, Preferenz P300, BiotouchROC, BIOPROTEASAL 800ST, Bioproteasa 800P, Bioproteasa L800, Pro 114 LS, Progress Uno EC 100 L, Progress Uno 100 L, Progress Uno 101 L, EFFECTENZ TM P 100(A01339), EFFECTENZ TM P 150, EC 16 L, EC 24 T, 16L, 24T、ExcellenzP 1250、 EC 150 T, 150 T, 125 T, Blaze Evity 16 L, Excelllase, Purafect, Purafect OxP, PurafectPrime, Properase, Pro EC 100L, Pro 100 L, Blaze Exceed 100 T, Progress Key 150 T, Progress Excel 101 L.

[0137] Preferred proteases for inclusion in the compositions according to the invention are 2.5L.

[0138] Suitable amylases for use herein may be alpha-amylases or glucoamylases and may be of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, such as a special strain of Bacillus licheniformis, described in more detail in GB 1,296,839.

[0139] Examples of amylases are alpha-amylases from Bacillus licheniformis, from Bacillus amyloliquefaciens or from Bacillus stearothermophilus, in particular their improved further developments for use in detergents or cleaners.

[0140] The enzyme from Bacillus licheniformis may be referred to by the name Obtained from Novozymes and under the name ST was obtained from Danisco / Genencor.

[0141] Further developments of this α-amylase are available under the trade name and ultra was obtained from Novozymes under the name OxAm was obtained from Danisco / Genencor, and as Obtained from Daiwa Seiko Inc., Tokyo, Japan.

[0142] α-Amylase from Bacillus amyloliquefaciens is marketed by Novozymes under the name Sold and under the name and Also from Novozymes, a variant of an alpha-amylase derived from Bacillus stearothermophilus.

[0143] Furthermore, alpha-amylases from Bacillus sp. A 7-7 (DSM 12368) and cyclodextrin glucanotransferases (CGTases) from Bacillus agaradherens (DSM 9948) should be emphasized.

[0144] Amylolytic enzymes disclosed in International Patent Applications WO 03 / 002711, WO 03 / 054177 and WO 07 / 079938 may also be used.

[0145] Fusion products of all the molecules mentioned can also be used. Further developments of alpha-amylases from Aspergillus niger and A. oryzae from Novozymes are suitable. Other commercial products that can be used advantageously are for example and or Stainzyme or Stainzyme The latter is also from Novozymes. Variants of these enzymes obtainable by point mutations can also be used according to the invention.

[0146] Other commercially available amylases are: Amplify Prime EC 110L, Amplify Prime 100L, PREFERENZS110, Bioamyl P, Stainzyme Plus Evity, Plus EC 12T, Plus EC 24T, Plus 24 T, EFFECTENZ TM S100, EFFECTENZ TM S210, Bialfa T, Achieve Alpha EC 110 L, Achieve Alpha 100 L, Advance 150 T, Stainzyme, Amplify, Duramyl, Novamyl.

[0147] Amplify TM Prime 100L is preferably comprised in the compositions according to the invention.

[0148] Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, such as Humicola insolens, Myceliophthorathermophila and Fusarium oxysporum disclosed in U.S. Patent Nos. 4,435,307, 5,648,263, 5,691,178, 5,776,757 and WO 89 / 09259.

[0149] Examples of cellulases (endoglucanases, EG) are fungal endoglucanases (EG)-rich cellulase preparations or further developments thereof, which are marketed by Novozymes under the trade name supply.

[0150] Also available from Novozymes and Based on 50 kD-EG or 43 kD-EG from Humicolainsolens DSM 1800. Other commercial products from this company that can be used are and You can also use, for example, a trade name and A cellulase obtained from AB Enzymes, Finland and based at least in part on 20 kD EG from Melanocarpus. Other cellulases from AB Enzymes are and Further suitable cellulases are derived from Bacillus sp. CBS 670.93 and CBS 669.93. The cellulase derived from Bacillus sp. CBS 670.93 from Danisco / Genencor is available under the trade name get.

[0151] Other commercial products from Danisco / Genencor that may be used are "Genencor detergent cellulase L" and Neutra.

[0152] Other commercially available cellulases are: PremiumEC 4510L, Premium EC 5000T, Premium 4500L, Premium 5000T, REVILATENZ 200, BiotouchDCL / FCL, Biosoft L Pure, Rocksoft, Retrocell, RetrocellZircoN, Puradax EG 7000L, Biotouch FCC, BIOCELULASA MC L, BIOCELULASA MC P, EC 5000L, 5000L, REVILATENZ 200, Biotouch FLX, C Bright 100L, EC 4500T, 4500T, Biotouch DCC.

[0153] Further preferred enzymes present in the composition of the invention are those known under the term glycosidase (EC 3.2.1.x). These include in particular arabinases, fucosidases, galactosidases, galactanases, arabico-galactan-galactosidases, mannanases (also called mannosidases or mannanases), glucuronidases, agarases, carrageenases, pullulanases, β-glucosidases, xyloglucanases (xylanases), xanthanases and pectin-degrading enzymes.

[0154] Preferred glycosidases are also summarized under the term hemicellulase. Hemicellulases include in particular mannanases, xyloglucanases (xylanases), beta-glucosidases and carrageenases as well as pectinases, pullulanases and beta-glucanases. Pectinases are pectin degrading enzymes, in particular hydrolytic pectin degrading enzymes belonging to enzyme classes EC 3.1.1.11, EC 3.2.1.15, EC 3.2.1.67 and EC 3.2.1.82. In the present invention, pectinases also include pectin lyase, pectin esterase, pectin demethoxylase, pectin methoxylase, pectin methylesterase, pectinase, pectin methylesterase, pectin esterase, pectin-galle-lactase, pectin-gal-galactosid ... ), pectin-gal-galase, pectin-gal-galonase, pectin-galactolase, endopoly-nolase, pectin-poly-galase, pectin-polyhydrolase, pectin-poly-galase, pectin-polyhydrolase, pectin-poly-galase, pectin-poly-galactosidase, pectin-poly-galactosidase-a-1,4-galacturonide glycanohydrolase), endogalacturonase, endo-D-galacturonase, galacturon 1,4-a-galacturonase,4-a-galacturonidase), exopolygalacturonase, poly(galacturonate) hydrolase, exo-D-galacturonase, exo-D-galacturonanase-Galacturonase, exo-poly-a-galacturonosidase, exopolygalacturonosidase or exopolygalacturanosidase.

[0155] Examples of suitable enzymes in this respect are for example those from Novozymes under the name Pektinex or The name from AB Enzymes is B1 L, and the name from Diversa Corp., San Diego, CA, USA of enzymes.

[0156] β-glucanase obtained from Bacillus subtilis may be referred to under the name Obtained from Novozymes.

[0157] Particularly preferred glycosidases or hemicellulases according to the invention are mannanases, which are available for example from Novozymes under the trade name or by Danisco / Genencor under the trade name supply.

[0158] Examples of commercially available mannanases are: EC 200L, EC 108L, 200L, 100L, PREFERENZ M100, Biotouch M, Biomananasa2XL.

[0159] The mannanase preferably comprised in the composition according to the invention is 4.0L.

[0160] Examples of commercially available pectate lyases are: EC 1000L, EC 1000T, 1000L 1000T, PREVERENZ F 1000, Pectex Pure, Pro 106L, Pro 106LS.

[0161] Examples of commercially available licheninases are: Lift INTENT 100L, Lift INTENT 100T.

[0162] Suitable lipases and cutinases include those of bacterial or fungal origin. Chemically modified or protein engineered mutant enzymes are included. Examples of lipases or cutinases are those originally from Humicola lanuginose (Thermomyces lanuginosus) or further developed therefrom, in particular those with the amino acid substitution D96L. They are available, for example, from Novozymes under the trade name Ultra, and sell.

[0163] Another lipase that can be advantageously used is available under the trade name Obtained from Novozymes.

[0164] Furthermore, for example, cutinases originally isolated from Fusarium solani pisi and Humicola insolens may be used. Lipases which may also be used are known under the name Lipase Lipase Lipase or Lipase Lipase Bacillis sp. Lipase Lipase and Lipase Available from Amano. For example, lipases or cutinases from Danisco / Genencor can be used, the starting enzymes originally isolated from Pseudomonas mendocina and Fusarium solanii. Other important commercial products are the preparation M1 originally sold by Gist-Brocades (now Danisco / Genencor). and And under the name Lipase Lipase and Lipase Those from Meito Sangyo KK, Japan, and products from Danisco / Genencor

[0165] Other examples of commercially available lipases are: EC 100L, EC 100 T, EC 200 L, 100L 100 T, 200 L, PREFERENZ L 100, Biolipasa 2XL, Biolipasa L, Biolipasa P, Lipoclean, Lipolase, Lipolase Ultra.

[0166] The lipase preferably included in the composition according to the invention is Lipex TM 100L Evity.

[0167] An example of a commercially available phosphodiesterase is: Pristine from Novozyme.

[0168] Suitable peroxidases / oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of available peroxidases include peroxidases from Coprinus, for example from C. cinereus, and variants thereof, such as those described in WO 93 / 24618, WO 95 / 10602 and WO 98 / 15257.

[0169] Commercially available peroxidases include Guardzyme TM (Novozymes A / S).

[0170] A preferred composition according to the invention is characterized in that it comprises

[0171] 2.0 to 60% by weight, preferably 5.0 to 40% by weight, more preferably 10.0 to 30% by weight of the sum of A) and B), as the case may be

[0172] C) in an amount of 0.2 to 10% by weight, preferably 1.0 to 8.0% by weight, more preferably 1.5 to 6.0% by weight,

[0173] The weight percentages are based on the total composition.

[0174] A preferred composition according to the invention is characterized in that it comprises

[0175] At least one non-biological surfactant is preferably selected from anionic surfactants, cationic surfactants, nonionic surfactants, semi-polar surfactants, amphoteric surfactants and zwitterionic surfactants.

[0176] Preferably, the non-biological surfactant is selected from fatty alcohol alkoxylates.

[0177] These can be advantageously used for cleaning the surfaces of textiles or fabrics containing polyamines.

[0178] Non-limiting examples of anionic surfactants include sulfates and sulfonates, particularly linear alkylbenzene sulfonates (LAS), isomers of LAS, branched alkylbenzene sulfonates (BABS), phenylalkane sulfonates, α-olefin sulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2,3-diyl bis(sulfates), hydroxyalkane sulfonates and disulfonates, alkyl sulfates (AS) such as sodium dodecyl sulfate (SDS), fatty alcohol sulfates (FA), primary alcohol sulfates (PAS), alcohol ether sulfates (AES or AEOS or FES, also known as alcohol ethoxysulfates or fatty alcohol ether sulfates), secondary alkane sulfonates (SAS), paraffin sulfonates (PS), ester sulfonates, sulfonated fatty acid glycerides, α-sulfo fatty acid methyl esters (α-SFME or SES), including methyl ester sulfonates (MES), alkyl or alkenyl succinic acid, dodecenyl / tetradecenyl succinic acid (DTSA), fatty acid derivatives of amino acids, diesters and monoesters of sulfosuccinic acid or soap, and combinations thereof.

[0179] Non-limiting examples of cationic surfactants include alkyl dimethyl ethanol ammonium quat (ADMEAQ), cetyl trimethyl ammonium bromide (CTAB), dimethyl distearyl ammonium chloride (DSDMAC), and alkyl benzyl dimethyl ammonium, alkyl quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, and combinations thereof.

[0180] Non-limiting examples of nonionic surfactants include alcohol ethoxylates (AE or AEO) (which are preferably included in the composition according to the present invention), alcohol propoxylates, propoxylated fatty alcohols (PFA), alkoxylated fatty acid alkyl esters, such as ethoxylated and / or propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (APE), nonylphenol ethoxylates (NPE), alkyl polyglycosides (APG), alkoxylated amines, fatty acid monoethanolamide (FAM), fatty acid diethanolamide (FADA), ethoxylated fatty acid monoethanolamide (EFAM), polyglycerol esters, glycerides, propoxylated fatty acid monoethanolamide (PFAM), polyhydroxyalkyl fatty acid amides, or N-acyl N-alkyl derivatives of glucosamine (glucamide, GA, or fatty acid glucamide, FAGA), as well as products available under the trade names SPAN and TWEEN, and combinations thereof.

[0181] Non-limiting examples of semi-polar surfactants include amine oxides (AOs), such as alkyl dimethyl amine oxides, N-(coconut alkyl)-N,N-dimethyl amine oxides, and N-(tallow alkyl)-N,N-bis(2-hydroxyethyl) amine oxides, fatty acid alkanolamides, and ethoxylated fatty acid alkanolamides, and combinations thereof.

[0182] Non-limiting examples of amphoteric and zwitterionic surfactants include betaines, alkyl dimethyl betaines, sulfobetaines, hydroxysulfobetaines, and combinations thereof.

[0183] Furthermore, bio-based surfactants which are not based on glycolipids may be included in the compositions according to the invention, for example lipopeptides such as surfactins or phospholipids such as phosphatidylcholine.

[0184] The composition according to the invention may further comprise one or more auxiliaries selected from bleaching systems, hydrotropes, polymers (which may be synthetic), biopolymers, anti-redeposition aids, fiber protectants, soil release agents, dye transfer inhibitors, fabric hueing agents, opacifying agents, bluing dyes, enzyme stabilizers, solvents, viscosity improvers, preservatives, pH adjusters and salts such as NaCl and Na 2 SO 4 .

[0185] Any polymer known in the art for use in detergents may be used. The polymer may act as a co-builder as described above, or may provide anti-redeposition, fiber protection, soil removal, dye transfer inhibition, viscosity improver, grease cleaning and / or defoaming properties. Exemplary polymers include (carboxymethyl) cellulose (CMC), poly(vinyl alcohol) (PVA), poly(vinyl pyrrolidone) (PVP), poly(ethylene glycol) or poly(ethylene oxide) (PEG), ethoxylated poly(ethylene imine), carboxymethyl inulin (CMI), and polycarboxylates such as PAA, PAA / PMA, polyaspartic acid and lauryl methacrylate / acrylic acid copolymers, hydrophobically modified CMC (HM-CMC) and silicones, copolymers of terephthalic acid and oligomeric glycols, copolymers of poly(ethylene terephthalate) and poly(oxyethylene terephthalate) (PET-POET), PVP, poly(vinylimidazole) (PVI), poly(vinylpyridine-N-oxide) (PVPO or PVPNO), and polyvinylpyrrolidone-vinylimidazole (PVPVI). Additional exemplary polymers include sulfonated polycarboxylates, polyethylene oxide and polypropylene oxide (PEO-PPO), and diquaternary ammonium ethoxysulfates. Other exemplary polymers are disclosed, for example, in WO 2006 / 130575. Salts of the above polymers are also contemplated.

[0186] Preferably, the composition according to the invention is characterized in that it comprises

[0187] At least one selected from anti-redeposition polymers and soil release polymers, wherein soil release polymers are preferred. This has the technical effect of further enhancing the cleaning ability of the composition according to the invention. In combination with glycolipids with a sugar ring in the molecule, such as monorhamnolipids and glucose lipids of formula (III), a surprising increase in viscosity can be observed.

[0188] It is preferred in the present invention that the anti-redeposition polymer or soil release polymer is selected from the group comprising, preferably consisting of, modified cellulose, preferably carboxymethyl cellulose, cellulose acetate and methyl cellulose, modified starch, modified inulin, preferably carboxymethyl inulin, polyitaconic acid, polyvinyl pyrrolidone, polyvinyl alcohol and polyethylene glycol, of which carboxymethyl cellulose and methyl cellulose are most preferred.

[0189] Further preferred soil release polymers are water-soluble polyesters, for example from the group consisting of the polyols marketed under the names TexCare SRN 260, TexCare SRN 170, TexCare SRN 170 Terra, TexCare SRN 260SG Terra, TexCare SRN 260 Life and combinations thereof. series, and soil release polymers disclosed in EP3218461, EP3218465, EP3489340 and EP3489338.

[0190] A further preferred soil release polymer is selected from carboxymethyl inulin. A commercial example is CMI.

[0191] Soil release polymers of this type are particularly useful for promoting the viscosity increase induced by the content of glycolipids carrying one sugar ring in the molecule, such as monorhamnolipids and glucose lipids of formula (III).

[0192] EP1746109 discloses hybrid polymers of amylose and acrylates which may also be advantageously used as soil release polymers in the compositions of the present invention. A commercial example of this type of soil release polymer is H5941.

[0193] Non-limiting examples of biopolymers include starches such as corn starch, zea mays starch, and tapioca starch, modified starches such as starch hydroxypropyltrimonium chloride and hydrolyzed corn starch, cellulose, bacterial cellulose, modified celluloses such as microcrystalline cellulose, hydroxypropylmethylcellulose, and cetyl hydroxyethylcellulose, guar gum, pectin, inulin, carrageenan, alginates, galactoarabinan, polycitronellol, carboxymethyl inulin, carboxymethyl cellulose, polyitaconic acid, and combinations and salts thereof.

[0194] Suitable non-aqueous solvents include mono- or polyhydric alcohols, alkanolamines or glycol ethers, provided that they are miscible with water within the specified concentration range.

[0195] The solvent is preferably selected from ethanol, n-propanol, isopropanol, butanol, glycol, propylene glycol, butylene glycol, glycerol, diethylene glycol, propyl diglycol, butyl diglycol, hexylene glycol, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol propyl ether, n-butyl glycol ether, ethylene glycol mono-glycol ether, diethylene glycol ethyl ether, propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, diisopropylene glycol monomethyl ether, diisopropylene glycol monoethyl ether, methoxytriglycol, ethoxytriglycol, butoxytriglycol, 1-butoxyethoxy-2-propanol, n-butoxyethoxy-2-propanol, dibutoxyethoxy-2-propanol, 3-butyl-3-methoxy ether solvent, And mixtures of these solvents, butoxyethoxy-2-propanol, 3-butyl-3-butyl ether, propyl glycol, dioctanol ether, dibutoxy-2-propanol, 3-butyl-3-butyl ether, propanol, propylene glycol, dibutoxyethoxy-2-propanol, dibutoxyethoxy-2-propanol, 3-butoxy-3-methoxy ether solvent, diisopropylene glycol monomethyl ether, diisopropylene glycol monomethyl ether and mixtures of these solvents.

[0196] However, it is preferred that the surfactant formulation contains a polyol as the non-aqueous solvent. The polyol may comprise glycerol, 1,2-propylene glycol, 1,3-propylene glycol, ethylene glycol, diethylene glycol and / or dipropylene glycol.

[0197] Any preservative known in the art for use in detergents can be used. Exemplary preservatives include phenoxyethanol, sodium levulinate, sodium benzoate, p-methoxybenzoic acid, potassium sorbate, benzoic acid, glyceryl caprylate, caprylyl glycol, pentylene glycol, methylpropylene glycol, bronopol, isothiazolinone (methylisothiazolinone, chloromethylisothiazolinone) and combinations thereof.

[0198] Preferably, the composition according to the present invention comprises one or more encapsulates containing a benefit agent, preferably a sensory benefit agent. In this case, the preferred encapsulate comprises a shear / pressure sensitive encapsulate, whereby the sensory benefit agent is released in response to mechanical forces (e.g. friction, pressure, shear stress) on the encapsulate. The encapsulation shell is preferably composed of materials including but not limited to polyurethanes, polyamides, polyolefins, polysaccharides, proteins, silicones, lipids, modified celluloses, gums, polyacrylates, polyphosphates, polystyrenes, polyesters or combinations of these materials.

[0199] Preferably, the sensory benefit agent comprises a skin benefit agent or an olfactory benefit agent and / or can be a volatile benefit agent. The sensory benefit agent can also have benefits to hair and / or hard surfaces and / or fabrics. The sensory benefit may have defoaming properties, so it is advantageous for foaming purposes to encapsulate it so as not to interfere with the foam before releasing under friction. Suitable volatile benefit agents include, but are not limited to, spices, insect repellents, essential oils, sensory agents (sensates) such as menthol and aromatherapy actives, preferably spices. A mixture of volatile benefit agents can be used. Based on the gross weight of the composition, the total amount of benefit agent is preferably 0.01 to 10 weight %, more preferably 0.05 to 5 weight %, more preferably 0.1 to 4.0%, most preferably 0.15 to 4.0 weight %. Preferred benefit agents are spices. The composition of the present invention may also include non-enclosed (unconfined) (also referred to as non-encapsulated) volatile benefit agents. In the case where the volatile benefit agent is a spice, the spice described below is suitable for use as an encapsulated volatile benefit agent, and is also suitable for use as a non-encapsulated spice component.

[0200] Preferably, the viscosity of the composition according to the invention is in the range of 5 to 400, preferably 10 to 350, preferably 15 to 300 (measured: Brookfield LV, s61, 200 rpm, 20° C.).

[0201] Preferably, the composition according to the present invention has a turbidity of 0.005 to 5000, preferably 11.0 to 100 nephelometric turbidity units. The measurement of turbidity is carried out with a 2100Q portable turbidimeter, which measures the light intensity scattered at 90 degrees when the light beam passes through the liquid sample, giving a direct response in NTU. NTU is a unit for measuring the lack of clarity of a liquid and is used in, for example, water and sewage treatment facilities, marine research. For example, water containing 1 mg of finely divided silica per liter has a turbidity of 1NTU. The water to be measured is placed in a standard container. The light beam passes through the water and hits the sensor on the other side of the container. The second sensor is installed at right angles to the light beam to measure the light scattered by particles in the water. By the ratio between the light intensity at the two sensors, the turbidity in NTU can be calculated.

[0202] The composition as contemplated herein is preferably a detergent composition. It may be in any convenient form, such as a bar, a homogeneous tablet, a tablet with two or more layers, a pouch with one or more compartments, a conventional or compacted powder, a granule, a paste, a gel or a conventional, compressed or concentrated liquid. There are many detergent formulation forms, such as layers (same or different phases), pouches and forms for machine dosing units.

[0203] The pouch can be configured as a single compartment or multiple compartments. It can be any form, shape and material suitable for accommodating the composition, such as not allowing the composition to be released from the pouch before water contact. The pouch is made of a water-soluble film surrounding an internal volume. The internal volume can be divided into compartments of the pouch. The preferred film is a polymer material, preferably a polymer formed into a film or sheet. Preferred polymers, copolymers or derivatives thereof are selected from polyacrylates and water-soluble acrylate copolymers, methylcellulose, carboxymethylcellulose, sodium dextrin, ethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, maltodextrin, polymethacrylate, most preferably polyvinyl alcohol copolymers and hydroxypropylmethylcellulose (HPMC). Preferably, the content of the polymer (e.g., PVA) in the film is at least about 60%. The preferred average molecular weight is generally about 20,000 to about 150,000. The film may also be a blended composition comprising a hydrolytically degradable and water-soluble polymer blend, such as polylactic acid and polyvinyl alcohol (known as commercial designation M8630 sold by Chris Craft In. Prod. Of Gary, Ind., US) plus a plasticizer, such as glycerol, ethylene glycol, propylene glycol, sorbitol, and mixtures thereof. The pouch may comprise a solid laundry detergent composition or part of a component and / or a liquid cleaning composition or part of a component separated by a water-soluble film. The compartment for the liquid component may be different in composition from the compartment containing the solid, see, for example, US20090011970.

[0204] Detergent ingredients can be physically separated from each other by compartments in water-soluble bags or in different layers of a tablet. Negative storage interactions between components can thereby be avoided. Different dissolution profiles of each compartment can also provide delayed dissolution of selected components in the wash solution.

[0205] Detergent compositions according to the present invention can be in the form of laundry soap bars and are used for hand-washing clothes, fabrics and / or textiles. The term laundry soap bar includes laundry bars (laundry bars), soap bars, combo bars, synthetic detergent bars (syndetbars) and detergent bars (detergent bars). The type of bar is usually different in the type of surfactant they contain, and the term laundry soap bar includes those containing soap and / or synthetic soap from fatty acids. Laundry soap bars have a physical form that is solid rather than liquid, gel or powder at room temperature. The term solid is defined as a physical form that does not change significantly over time, that is, if a solid object (such as laundry soap bar) is placed in a container, the solid object will not change to fill the container in which it is located. The bar is a solid in the form of a common bar, but it can also be other solid shapes, such as circular or oval.

[0206] The detergent composition according to the present invention may be formulated as a granular detergent as described in WO09 / 092699, EP1705241, EP1382668, WO07 / 001262, US Pat. No. 6,472,364, WO04 / 074419 or WO09 / 102854.

[0207] The detergent composition according to the present invention is preferably in the form of a liquid or gel detergent. This can be aqueous, typically containing at least 20% by weight of water, wherein the percentage is referenced to the total composition. Other types of liquids, including but not limited to alkanols, amines, glycols, ethers and polyols, can be included in aqueous liquids or gels. Aqueous liquid or gel detergent compositions may contain 0-30% by weight of an organic solvent, wherein the percentage is referenced to the total composition. The liquid or gel detergent can be non-aqueous.

[0208] A preferred composition according to the invention is characterized in that the pH of the composition at 25° C. is from 3.0 to 10.0, preferably from 4.0 to 9.5, particularly preferably from 7.0 to 9.0.

[0209] Unless otherwise stated, "pH" with respect to the present invention is defined as the value measured according to ISO 4319 (1977) using a calibrated pH electrode on the relevant composition after stirring for 5 minutes at 25°C.

[0210] The present invention further provides a method for cleaning the surface of an article, preferably a textile or fabric, comprising the steps of

[0211] a) providing compositions and preparations according to the invention,

[0212] b) combining a provided composition and a provided article with water,

[0213] c) maintaining the temperature of water containing the provided composition and the provided article in the temperature range of 15°C to 100°C, preferably 25°C to 65°C, more preferably 35°C to 45°C for a period of 5 minutes to 240 minutes, preferably 10 minutes to 180 minutes, more preferably 20 minutes to 120 minutes, while temporarily moving the provided article in the water,

[0214] d) separating the product from water, and optionally

[0215] e) Rinse the article with additional water.

[0216] A preferred method according to the invention is characterized in that the weight ratio of the product provided in steps b) and c) to water is in the range of 1:2 to 1:30, preferably 1:3 to 1:25, more preferably 1:4 to 1:20.

[0217] A preferred process according to the invention is characterized in that in step b) from 0.1 g to 50 g, preferably from 1.0 g to 20 g, more preferably from 2.0 g to 10 g of the composition according to the invention are provided per kg of water.

[0218] The present invention further provides for the use of a composition according to the invention for cleaning the surface of an article, preferably a textile or fabric.

[0219] Preferably, the use according to the invention is characterized by cleaning fat and / or oil, preferably solid fat stains, from the surface of an article.

[0220] The examples cited below illustrate the invention by way of example without any intention of limiting the invention to the embodiments specified in the examples, the scope of application of the invention being apparent from the entire description and claims. Example

[0221] The rhamnolipid used was prepared as described in Example 1 of EP3061442 and analogously to the di-rhamnolipid; the mono-rhamnolipid was prepared as in Example 2 of EP3061442.

[0222] The sophorolipid used was the sophorolipid REWOFERM SL ONE from Evonik, which has a lactone to acid ratio of 40:60.

[0223] Glucose lipids were produced by fermentation according to Example 2 of WO2019154970.

[0224] Embodiment 1:

[0225] The following formulations were prepared, where the figures given are weight percentages of active substances, Base 1 and Base 2 (commercial detergents) and Base 3, Base 4 and Base 5 (in-house available detergents) are not according to the invention, and Detergents 1 to 6 are according to the invention:

[0226]

[0227]

[0228] Table 1

[0229]

[0230]

[0231] Table 2

[0232]

[0233] Table 3

[0234]

[0235]

[0236] Table 4

[0237]

[0238] Table 4B Benchmark 1 (commercial product)

[0239]

[0240]

[0241] Benchmark 2 (commercial product)

[0242]

[0243]

[0244]

[0245] Table 5

[0246] A stain removal test using a Linitest apparatus was conducted to evaluate the compositions in Tables 1 and 2. The Linitest apparatus was used for this test.

[0247] Table 6: Experimental conditions used for Linitest

[0248]

[0249]

[0250] Table 7: Stains used to test washing performance.

[0251]

[0252] The stains used were purchased from CFT (Vlaardingen, Nederland's), which are also recommended by AISE (Laundry Detergent Testing Guidelines).

[0253] After washing, the fabrics are rinsed and then air dried.

[0254] The evaluation of the degree of stain removal was performed as follows: Reflectance was measured by spectrophotometer, Y value using Y, x, y color coordinate measurement, light source D65 with UV cut filter at 420 nm. Aperture 15 mm for real stains (minimum 12 mm). The stains were spread out, each stain was measured 3 times (in the center of the circular area, or the area closest to uniformity), so 18 times per stain. Each stain was measured before washing (to verify the nature of the stain) and after washing, and the standard deviation was evaluated and reported.

[0255] The results are expressed as the average value of the value Y and its standard deviation (σ) between three repeated tests, and are shown in Tables 8 to 14. The better the soil removal, the larger the Y value.

[0256]

[0257]

[0258] Table 8

[0259]

[0260] Table 9

[0261]

[0262] Table 10

[0263]

[0264]

[0265] Table 11

[0266]

[0267] Table 12

[0268]

[0269] Table 13

[0270]

[0271]

[0272] Table 14

[0273] Result evaluation:

[0274] Surprisingly, it was found that adding the component persicomycin to a biosurfactant-based detergent formulation leads to better cleaning performance in terms of stain removal. Especially in the case of fatty stains, the combination outperforms formulations without persicomycin (benchmarks 3, 4 and 5) and commercial formulations (benchmarks 1 and 2). Furthermore, the addition of persicomycin leads to a higher overall formulation viscosity, which is very much in line with market and consumer expectations for liquid laundry detergents.

[0275] Additional Detergent Examples

[0276]

[0277] Table 15

[0278]

[0279] Table 16

[0280]

[0281] Table 17

[0282]

[0283] Table 18

[0284]

[0285]

[0286] Table 19

[0287]

[0288] Table 20

[0289]

[0290]

[0291] Table 21

[0292]

[0293] Table 22

[0294]

[0295]

[0296] Table 23

[0297]

[0298] Table 24

[0299]

[0300] Table 25

[0301]

[0302]

[0303] Table 26

[0304]

[0305] Table 27

[0306]

[0307]

[0308] Table 28

[0309]

[0310]

[0311]

[0312]

[0313]

[0314]

[0315]

[0316]

[0317]

[0318]

[0319]

[0320]

[0321]

[0322]

[0323]

[0324]

[0325]

[0326]

[0327]

[0328]

[0329]

[0330]

[0331]

[0332]

[0333]

[0334]

[0335]

[0336]

[0337]

[0338]

[0339]

[0340]

[0341]

[0342]

[0343]

[0344]

[0345]

[0346]

[0347]

[0348]

[0349]

[0350]

[0351]

[0352]

[0353]

[0354]

[0355]

[0356]

Claims

1. A composition comprising A) at least one biosurfactant, and B) at least one persicomycin.

2. The composition according to claim 1, characterized in that The biosurfactant is selected from rhamnolipids, glucose lipids and sophorolipids, preferably rhamnolipids and glucose lipids, and most preferably rhamnolipids.

3. The composition according to claim 1 or 2, characterized in that The ratio of component B) to component A) is from 1:2000 to 1:3, preferably from 1:1000 to 1:10, more preferably from 1:300 to 1:20, most preferably from 1:100 to 1:

25.

4. Composition according to at least one of the preceding claims, characterized in that It comprises C) at least one enzyme, preferably selected from the group consisting of proteases, amylases, lipases, pectinases, cellulases, phosphodiesterases, mannanases, cutinases, pectate lyases, peroxidases, oxidases and laccases.

5. Composition according to at least one of the preceding claims, characterized in that It contains the sum of A) and B) in an amount of 2.0 to 60% by weight, preferably 5.0 to 40% by weight, more preferably 10.0 to 30% by weight, as the case may be. C) in an amount of 0.2 to 10% by weight, preferably 1.0 to 8.0% by weight, more preferably 1.5 to 6.0% by weight, The weight percentages are based on the total composition.

6. Composition according to at least one of the preceding claims, characterized in that It comprises at least one non-biological surfactant, preferably selected from anionic surfactants, cationic surfactants, nonionic surfactants, semi-polar surfactants, amphoteric surfactants and zwitterionic surfactants.

7. Composition according to at least one of the preceding claims, characterised in that It comprises at least one selected from anti-redeposition polymers and soil release polymers.

8. The composition according to claim 7, characterized in that The anti-redeposition polymer or soil release polymer is selected from modified cellulose, preferably carboxymethyl cellulose, cellulose acetate and methyl cellulose, modified starch, modified inulin, preferably carboxymethyl inulin, polyitaconic acid, polyvinyl pyrrolidone, polyvinyl alcohol and polyethylene glycol.

9. A method for cleaning the surface of an article, preferably a textile or fabric, comprising the steps of a) providing a composition and a preparation according to at least one of the preceding claims, b) combining a provided composition and a provided article with water, c) maintaining the temperature of water containing the provided composition and the provided article in the temperature range of 15°C to 100°C, preferably 25°C to 65°C, more preferably 35°C to 45°C for a period of 5 minutes to 240 minutes, preferably 10 minutes to 180 minutes, more preferably 20 minutes to 120 minutes, while temporarily moving the provided article in the water, d) separating the product from water, and optionally e) Rinse the article with additional water.

10. The method according to claim 9, characterized in that The weight ratio of the product provided in steps b) and c) to water is from 1:2 to 1:30, preferably from 1:3 to 1:25, more preferably from 1:4 to 1:

20.

11. The method according to claim 9 or 10, characterized in that In step b), 0.1 g to 50 g, preferably 1.0 g to 20 g, more preferably 2.0 g to 10 g of the composition according to any one of claims 1 to 8 are provided per kg of water.

12. Use of a composition according to at least one of claims 1 to 8 for cleaning the surface of an article, preferably a textile or fabric.

13. The use according to claim 12, characterized in that Cleaning fat and / or oil from the surface of the article.

Citation Information

Patent Citations

  • Use of mixture of glyco-lipid and surfactant in hand dish-washing detergent

    DE19600743A1

  • Skin-friendly washing=up liquid with good cleaning performance

    DE19648439A1

  • cosmetic preparation

    DE2939519A1

  • Inducing rhamno:lipid synthesis in Pseudomonas aeruginosa - with glyceric acid ether lipid, to form intermediate for rhamnose which is used in synthesis of chiral cpds.

    DE4127908A1

  • Method for producing rhamnose

    EP0282942A2